Last reviewed · How we verify

NCT07074613: ART-Walk

Augmented Reality Treadmill Walking for Cognitive and Physical Health in Older Adults

Completed NA Last updated 20 July 2025
What this trial tests

NA trial testing Traditional Treadmill Walking in Aging in 60 participants. Completed in 5 January 2025.

Timeline
6 December 2024
Primary endpoint
5 January 2025
5 January 2025

Quick facts

Lead sponsorNational Taiwan College of Performing Arts
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment60
Start date6 December 2024
Primary completion5 January 2025
Estimated completion5 January 2025
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Taiwan College of Performing Arts

Who can join

Adults 65 to 80, any sex, with Aging or Cognitive Decline. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluated the feasibility and health effects of using augmented reality (AR) treadmill walking in older adults. Sixty community-dwelling adults aged 65 to 80 years were randomly assigned to either an AR treadmill group or a traditional treadmill group. Both groups participated in supervised walking sessions three times per week for twelve weeks. The study examined changes in mobility, balance, body composition, physiological responses, and participants' perceptions of the AR technology.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07074613.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing